Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

February 1, 2023

Parkinson's patients show improvement in study by Portland company

Portland-based MedRhythms has completed a study that revealed an enhanced quality of life for those with Parkinson's disease. 

According to the MedRhythm press release, the feasibility study showed positive results in developing the treatment of changes in regular walking patterns (gait deficits). The preliminary results showed improvement in patients' motor control symptoms related to their walking capacity and functional mobility.

Mitchell Institute
Brian Harris

"In successfully completing our first clinical trial in Parkinson's disease in collaboration with Boston University and one of the world's leading hospitals, we have made significant progress on the advancement of our pipeline," said Brian Harris, CEO and co-founder of MedRhythms. "The clinical feasibility from this trial and our recently completed pivotal trial in chronic stroke is essential as we work toward our goal of building next-generation neurotherapeutics that are evidence-based and can positively impact the lives of patients around the world."

Dr. Terry Ellis, an associate professor and chair of the department of physical therapy at the Boston University College of Health & Rehabilitation Sciences, was one of the principal investigators in the study.

"The results from this study related to adherence and early signals of clinical improvements with Parkinson's disease patients are compelling and suggest that this could be a promising intervention for improving gait deficits in this population," said Ellis."I look forward to conducting further research to investigate the impact of this intervention on people who are diagnosed with Parkinson's disease."

The results of this study will be submitted for a peer-reviewed publication and presented at the upcoming American Physical Therapy Association Combined Sections meeting. A follow-up clinical study of adults with Parkinson's disease is now underway.

MedRhythms is a digital therapeutics company focused on the intersection of music, neuroscience and technology. Harris and his partner Owen McCarthy were named Mainebiz Next list honorees in 2018.

Sign up for Enews

Related Content


Order a PDF